The fund aims to produce a rising income with capital growth from a portfolio primarily made up of investments in the UK including ordinary shares, convertibles and fixed interest securities.
Name | % Net Assets |
---|---|
BP | 5.0% |
HSBC | 4.9% |
GlaxoSmithKline | 4.5% |
Vodafone | 3.3% |
Royal Dutch Shell 'B' | 3.2% |
Legal & General Group | 3.1% |
Rio Tinto | 3.1% |
BT | 2.9% |
Reed Elsevier | 2.8% |
Centrica | 2.5% |
Key | % Net Assets |
---|---|
BP | 5.0% |
HSBC | 4.9% |
GlaxoSmithKline | 4.5% |
Vodafone | 3.3% |
Other | 82.3% |
Date | 13-Nov-2024 |
---|---|
NAV | 590.35p |
Currency | GBP |
Change | -3.92p |
% | -0.66% |
YTD change | 51.94p |
YTD % | 9.65% |
Fund Inception | 06/06/2000 |
---|---|
Fund Manager | Adrian Frost / Adrian Gosden |
TER | 1.55 (31-May-2012) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | £1,000 |
Savings | £50 |
Charges | |
---|---|
Initial | 5.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.16 |
You are here: research